Stay updated on Pembrolizumab in SCLC Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab in SCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab in SCLC Clinical Trial page

  1. Check
    yesterday
    No Change Detected
  2. Check
    8 days ago
    No Change Detected
  3. Check
    15 days ago
    Change Detected
    Summary
    - Locations: New York added as a study site. - Deletions: HHS Vulnerability Disclosure and New York Locations removed; revision updated from v3.3.2 to v3.3.3.
    Difference
    0.2%
    Check dated 2025-12-24T15:24:44.000Z thumbnail image
  4. Check
    23 days ago
    No Change Detected
  5. Check
    44 days ago
    Change Detected
    Summary
    Revision tag updated from v3.2.0 to v3.3.2. This appears to be a minor version update with no impact on study content.
    Difference
    0.1%
    Check dated 2025-11-25T14:43:38.000Z thumbnail image
  6. Check
    52 days ago
    Change Detected
    Summary
    The government funding lapse notice was removed from the page. The study content, endpoints, and eligibility criteria remain unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2025-11-18T07:31:53.000Z thumbnail image
  7. Check
    73 days ago
    Change Detected
    Summary
    The study record now displays Terminated status with the reason that standard of care for small cell lung cancer changed in 2018. Enrollment, primary completion, and study completion dates have been updated to reflect the termination.
    Difference
    0.4%
    Check dated 2025-10-27T21:01:10.000Z thumbnail image
  8. Check
    94 days ago
    Change Detected
    Summary
    Added government funding/status notice and new version v3.2.0; removed a specific resource entry (Small cell lung carcinoma) and older version v3.1.0.
    Difference
    3%
    Check dated 2025-10-06T08:11:26.000Z thumbnail image
  9. Check
    102 days ago
    Change Detected
    Summary
    - Updated version from v3.0.2 to v3.1.0. - No other content changes detected.
    Difference
    0.1%
    Check dated 2025-09-29T04:44:51.000Z thumbnail image

Stay in the know with updates to Pembrolizumab in SCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab in SCLC Clinical Trial page.